About Us
![cures-within-reach-diseases-researched clinical research for unsolved diseases](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-diseases-researched.png)
Diseases Researched
![cures-within-reach-repurposing-funded repurposing research grants funding](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-repurposing-funded.png)
Repurposing Trials Funded
![cures-within-reach-institutions-funded cures-within-reach-institutions-funded](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-institutions-funded.png)
Institutions Funded
![cures-within-reach-diseases-improved cures-within-reach-diseases-improved](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-diseases-improved.png)
Success Stories
![cures-within-reach-startups startups-investing-in-repurposing-research](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-startups.png)
Startups with CWR Investments
![cures-within-reach-companies-commercializing cures-within-reach-companies-commercializing](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-companies-commercializing.png)
Companies Commercializing CWR Projects
![cures-within-reach-millions-project-funding millions-project-funding-for-repurposing-research](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-millions-project-funding.png)
Millions of Dollars in Clinical Trial Funding
![cures-within-reach-follow-on-funding repurposing-research-initiated -follow-on-funding supporting clinical research](https://www.cureswithinreach.org/wp-content/uploads/2020/07/cures-within-reach-follow-on-funding.png)
Millions of Dollars in Follow-on Funding Leveraged
Our mission is to leverage the speed, safety and cost-effectiveness repurposing – testing already approved therapies for unsolved diseases: driving more treatments to more patients more quickly.
Cures Within Reach is the philanthropic leader in drug, device and nutraceutical repurposing research, which has the potential to transform the lives of patients with unsolved diseases by delivering treatments that can be used in the near-term. Our focus: we find and fund proof-of-concept clinical trials that, once successful, de-risk and catalyze follow-on funding for the larger, confirmatory trials, building the clinical evidence required for regulatory approval or to support off-label use by patients everywhere.
Our Value Proposition
Together with our donor-partners, we bring treatment options to the millions who suffer with unsolved diseases. Our nearly 20-year successful track record in repurposing is complementary to lengthy de novo therapy research and has the potential to significantly reduce the time needed to reach as many patients as possible. Together with our donor partners, we are de-risking new treatment options for patients, supporting researchers who have the clinical repurposing ideas to quickly reach patients everywhere. Donor partners choose their desired level of engagement in the design, search and selection process – our experienced team customizes the approach with each donor. Grants starting at $60,000 and up to $250,000 can support a small, proof-of-concept human clinical trial or an expansion of an ongoing trial.
We provide:
- An expert team providing bespoke services designed to meet your needs
- Technical expertise in finding, selecting, de-risking and managing our funded clinical trials
- Access to our vast global research network
- An efficient, proven RFP process, including external Grant Review Committee members representing research, industry, clinicians and the patient/community voice that support selection and strengthen trial protocols
- Project and financial progress reports both during and after the clinical trials
Our History
![Judy and George Goldman](https://www.cureswithinreach.org/wp-content/uploads/2020/09/JudyandGeorge-Goldmam-photo-222x300.png)
Judy and George Goldman
In 1998, Goldman Philanthropic Partners (GPP), a private operating foundation, was founded to accelerate the discovery of new treatments to improve the quality of life for people with catastrophic diseases. Dr. Bruce Bloom, currently the Chief Collaboration Officer of Healx, became Executive Director of Goldman Philanthropic Partnerships (GPP) in 2002. In 2005, Partnership for Cures was established as a 501(c)(3) public charity to carry on the GPP mission, and in 2009, we narrowed our focus to repurposing research, with Bruce as President & Chief Science Officer of our newly-focused nonprofit.
In 2012, we formally changed our name to Cures Within Reach to better reflect the focus of its mission: repurposing drugs, devices, nutraceuticals, and other treatments to drive more treatments to more patients more quickly. In 2017, Bruce became CEO of Cures Within Reach, and Barbara Goodman joined the leadership team. In 2019, Bruce left to pursue other opportunities.
Cures Within Reach’s commitment has always been:
- Alleviating suffering and bringing hope to those dealing with life-threatening illness.
- Challenging research institutions to support alternative approaches for research and funding that may lead to medical breakthroughs.
- Inspiring and funding researchers with innovative ideas that might otherwise remain unexplored.
- Honoring a donor’s unique motivation to have an impact on the pursuit of treatments and cures.
Fiscal Sponsorship
Cures Within Reach, throughout the years, has supported early-stage nonprofits during their development phase, as well as supporting research funding by such nonprofits through support services, scientific oversight, research sourcing and management. Currently, our fiscal sponsoree is the Judy Hirsch Foundation. In the past, we’ve provided support for funds from The American Center(s) for Cures, the CRAVAT Foundation, Cures Within Reach for Cancer (now called Reboot Rx), Dogs for Cures, FD Now, Mission: Cure, Noah’s Hope, Hope4Bridget, Jasper Against Batten, Lloyd Kupferberg Cancer Research Fund, and the PIC Foundation.